IP Library Granted Patent US 9,138,414
Granted Patent B1
US 9,138,414 · App. 11/855,807 · Granted Sep 22, 2015

Calcium supplement having enhanced absorption

Inventors: Kevin W. Lang (Lloyd Neck, NY); Gregory B. Murphy (Sands Point, NY); Gregory E. Urbanski (Sahuarita, AZ)
Assignee: Delavau LLC
A61K9/2054
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,138,414
App. No.
11/855,807
Granted
Sep 22, 2015
Kind
B1
Abstract

Dietary calcium supplements comprising highly bioavailable forms of calcium carbonate and methods of using these calcium carbonate forms to improve calcium balance, strengthen bones, and prevent, treat, and/or ameliorate bone loss associated with osteoporosis are provided.

Claims (34)

1. A confectionery comprising (1) a USP grade calcium carbonate powder having a particle size distribution characterized by a D 50 value, on a volume basis between about 9.8 μm and about 13.5 μm, a D 90 value, on a volume basis, between about 26.1 μm and about 31.7 μm, and at least 30% of the total volume of particles having sizes between about 1 μm and about 11 μm, a mode between 18.00 and 23.81 μm, a mean between 12.99 and 14.31 μm, a D[3,2] value between 2.39 and 2.53 μm, a mean/median ratio of 1.15 to 1.62, a coefficient of variation (%) between 77.2 and 79.3, and a specific surface area from 8753 to 9268 cm 2 /g; and (2) at least about 400 I.U. of vitamin D.

2. A pharmaceutical composition comprising: (1) a USP grade calcium carbonate powder having a particle size distribution characterized by a D 50 value, on a volume basis, between about 9.8 μm and about 13.5 μm, a D 90 value, on a volume basis, between about 26.1 μm and about 31.7 μm, and at least 30% of the total volume of particles having sizes between about 1 μm and about 11 μm, a mode between 18.00 and 23.81 μm, a mean between 12.99 and 14.31 nm, a D[3,2] value between 2.39 and 2.53 nm, a mean/median ratio of 1.15 to 1.62, a coefficient of variation (%) between 77.2 and 79.3, and a specific surface area from 8753 to 9268 cm 2 /g; and (2) at least about 400 I.U. of vitamin D.

3. A multi-vitamin comprising:

(1) a USP grade calcium carbonate powder having a particle size distribution characterized by a D 50 value, on a volume basis, between about 9.8 μm and about 13.5 μm, a D 90 value, on a volume basis, between about 26.1 μm and about 31.7 μm, and at least 30% of the total volume of particles having sizes between about 1 μm and about 11 μm, a mode between 18.00 and 23.81 μm, a mean between 12.99 and 14.31 μm, a D[3,2] value between 2.39 and 2.53 μm, a mean/median ratio of 1.15 to 1.62, a coefficient of variation (%) between 77.2 and 79.3, and a specific surface area from 8753 to 9268 cm 2 /g; and

(2) one or more vitamins selected from the group consisting of:

between 1 and about 35,000 IU of vitamin A;

between 1 and about 1,000 mg of vitamin C;

between 1 and about 4,000 IU of vitamin D;

between 1 and about 450 IU of vitamin E;

between 1 and about 250 mcg of vitamin K;

between 1 and about 15 mg of vitamin B-1 (thiamin);

between 1 and about 17 mg of vitamin B-2 (riboflavin);

between 1 and about 200 mg of vitamin B-3 (niacin);

between 1 and about 100 mg of vitamin B-5 (pantothenic acid);

between 1 and about 30 mg of vitamin B-6 (pyridoxine);

between 1 and about 4,000 mcg of vitamin B-9 (folic acid);

between 1 and about 250 mcg of vitamin B-12 (cobalamin); and

between 1 and about 1,000 mcg of vitamin H (biotin);

and combinations thereof; and

(3) one or more minerals selected from the group consisting of:

between 1 and about 180 mg of iron;

between 1 and about 1,100 mg of phosphorous;

between 1 and about 1,500 mcg of iodine;

between 1 and about 4,000 mg of magnesium;

between 1 and about 150 mg of zinc;

between 1 and about 600 mcg of selenium;

between 1 and about 20 mg of copper;

between 1 and about 20 mg of manganese;

between 1 and about 2,000 mcg of chromium; and

between 1 and about 750 mcg of molybdenum;

between 0.001 and about 0.1 mg of tin;

between 1 and about 100 mcg of vanadium;

between 0.5 and 50 mcg of nickel;

and combinations thereof.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Feb 16, 2023
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: IVD, LLC
Reel/Frame 062714/0434 →
SECURITY INTEREST Recorded Feb 15, 2023
From: IVD, LLC
To: BMO HARRIS BANK N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 062699/0222 →
RELEASE OF SECURITY INTEREST Recorded Mar 5, 2019
From: CITIBANK, N.A.
To: INTERNATIONAL VITAMIN CORPORATION; IVP, LLC; IVD, LLC
Reel/Frame 048507/0897 →
SECURITY INTEREST Recorded Mar 5, 2019
From: IVD, LLC
To: JPMORGAN CHASE BANK, N.A.
Reel/Frame 048507/0924 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 21, 2018
From: DELAVAU L.L.C.
To: IVD, LLC.
Reel/Frame 046935/0331 →
SECURITY INTEREST Recorded Sep 19, 2018
From: IVD, LLC
To: CITIBANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 046909/0397 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 25, 2008
From: LANG, KEVIN W.; MURPHY, GREGORY B.; URBANSKI, GREGORY E.
To: DELAVAU LLC
Reel/Frame 020418/0901 →
Continuity (2)
Provisional Application 60825853 · Sep 15, 2006
Provisional Application 60892183 · Feb 28, 2007